Use of electrocardiometry for improving patient health and outcome after heart surgery in patients born with heart diseases

Clinical utility of electrocardiometry based parameters in the management of patients with congenital heart diseases undergoing corrective surgery - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060316

Enrollment

Registered

2023-11-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

Intervention1: Electrocardiometry monitoring: Electrocardiometry monitoring is used to manage patients undergoing corrective cardiac surgery for congenital heart diseases by constantly assessing cardi

Eligibility

Inclusion criteria

Inclusion criteria: Congenital heart disease patients between the age of 1day-15 years, posted for elective corrective surgery.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Emergencyprocedures 3. Cases that require re-exploration after the primary procedure. 4. Patients with univentricular heart diseases. 5. Patients requiring post-operative Extracorporeal membrane oxygenation support.

Design outcomes

Primary

Measure	Time frame
Incidence of post-operative Low Cardiac Output Syndrome (LCOS) Timepoint: Before induction of anaesthesia(T1), after induction of anaesthesia (T2), post sternotomy(T3), off CPB (T4), after sternal closure (T5), after shifting the patient to the ICU (T6) and the monitoring will be continued on to the 24th hour after surgery at 8hours (T7), 16hours (T8) and 24hours (T9) intervals after completion of surgery.	—

Measure

Time frame

Incidence of post-operative Low Cardiac Output Syndrome (LCOS) Timepoint: Before induction of anaesthesia(T1), after induction of anaesthesia (T2), post sternotomy(T3), off CPB (T4), after sternal closure (T5), after shifting the patient to the ICU (T6) and the monitoring will be continued on to the 24th hour after surgery at 8hours (T7), 16hours (T8) and 24hours (T9) intervals after completion of surgery.

—

Secondary

Measure	Time frame
1. Vasoactive Inotropic Score 2. Major adverse cardiac events 3. Input and Output balance 4. Lactate Level 5. Time till ICU and hospital discharge 6. Mortality Timepoint: Before induction of anaesthesia(T1), after induction of anaesthesia (T2), post sternotomy(T3), off CPB (T4), after sternal closure (T5), after shifting the patient to the ICU (T6) and the monitoring will be continued on to the 24th hour after surgery at 8hours (T7), 16hours (T8) and 24hours (T9) intervals after completion of surgery.	—

Measure

Time frame

1. Vasoactive Inotropic Score 2. Major adverse cardiac events 3. Input and Output balance 4. Lactate Level 5. Time till ICU and hospital discharge 6. Mortality Timepoint: Before induction of anaesthesia(T1), after induction of anaesthesia (T2), post sternotomy(T3), off CPB (T4), after sternal closure (T5), after shifting the patient to the ICU (T6) and the monitoring will be continued on to the 24th hour after surgery at 8hours (T7), 16hours (T8) and 24hours (T9) intervals after completion of surgery.

—

Countries

India

Contacts

Public ContactDr Rohan S Thottan

AIIMS, New Delhi

dr.rohan.s.thottan@gmail.com8754403502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026